Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Methodologies to Measure Blood Flow and Oxygenation as Potential Biomarkers in Adults With Sickle Cell Disease

NCT02447627 is registered in ClinicalTrials.gov with Bioverativ Therapeutics Inc. as lead sponsor.

NCT NCT02447627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Methodologies to Measure Blood Flow and Oxygenation as Potential Biomarkers in Adults With Sickle Cell Disease
Lead sponsor
Bioverativ Therapeutics Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
October 31, 2016
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, sickle cell disease